At MSF, we analyzed the spine industry and understand the value that a high quality niche product can provide to a physician and patients. That being said we have formed a strategic partnership with Coflex, a company that provides:
- The surgeon with a 3rd (unmatched) modality to treat patients with advanced, degenerative lumbar spinal stenosis.
- Neutral interlaminar stabilization post decompression.
- The ability to implant and load in the interlaminar space vs a spinous process implant.
- 2 and 4-year white paper studies to back up findings. (Soon to be 3 and 5-year data)
